Clinical trial
Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related…
NCT00001723 · Jack Yanovski, NIH · Completed
Key facts
| NCT number | NCT00001723 |
|---|---|
| Title | Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases |
| Official title | Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents With Obesity-Related Comorbid Conditions |
| Lead sponsor | Jack Yanovski, NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Hypertension, Metabolic Disease, Obesity, Sleep Apnea Syndrome |
| Intervention type | Drug |
| Interventions | Orlistat, Placebo |
| Enrollment | 200 |
| Start date | May 1, 1998 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Nov 4, 1999 |
| Last update posted | Dec 18, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: